Skip to content

BOK Financial BOKF Loans collectively evaluated for impairment - associated allowance

Loans collectively evaluated for impairment - associated allowance at other companies

JPMorgan Chase logo
JPMorgan ChaseJPM
Valley National Bank logo
Valley National BankVLY
Fifth Third Bank logo
Fifth Third BankFITB

Other financials

Income statement

See full
Revenue$553.8M+10.3%
Net income$155.8M+30.0%
EPS (diluted)$2.58+38.7%

Balance sheet

See full
Cash & equivalents$1.4B-0.3%
Total debt$228.1M-8.3%
Total equity$6.0B+3.5%
Total assets$53.8B+6.5%

Cash flow

See full
Operating cash flow-$248.7M-1,327%
CapEx$35.7M-25.9%
Free cash flow-$284.4M-917%

Valuation

See full
Market cap$7.92B+16.2%
P/E12.9×+0.7×
P/S3.6×+0.3×

Profitability

See full
Net margin27.6%+0.9pp
FCF margin64.7%+51.6pp

Returns & leverage

See full
Return on equity10.5%+0.2pp
Debt / equity0.0×

Where this comes from

Reported directly by BOK Financial in its filing.

Tagged under the XBRL concept us-gaap:FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment.

The official record: BOK Financial’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BOK Financial's loans collectively evaluated for impairment - associated allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BOK Financial's loans collectively evaluated for impairment - associated allowance?
BOK Financial (BOKF) reported loans collectively evaluated for impairment - associated allowance of $274.64M in Q1 2026.
How has BOK Financial's loans collectively evaluated for impairment - associated allowance changed year-over-year?
BOK Financial's loans collectively evaluated for impairment - associated allowance decreased by 1.4% year-over-year, from $278.59M to $274.64M.
What is the long-term trend for BOK Financial's loans collectively evaluated for impairment - associated allowance?
Over 5 years (2020 to 2025), BOK Financial's loans collectively evaluated for impairment - associated allowance has grown at a -5.9% compound annual growth rate (CAGR), from $366.2M to $269.67M.